| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05. | Nanologica AB: Bulletin from the Annual General Meeting 2026 Nanologica AB (publ) | 376 | GlobeNewswire (Europe) | Nanologica AB (publ) today May 21, 2026 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted.
Adoption of the income statement and balance sheet, disposition... ► Artikel lesen | |
| 20.05. | Nanologica AB: Interim Report Q1 2026 Nanologica AB (publ) | 458 | GlobeNewswire (Europe) | FINANCIAL SUMMARYNet sales for the first quarter amounted to SEK 21,456 thousand (10,751).Operating profit for the quarter amounted to SEK 66,484 thousand (-9,241). Operating profit is affected by the... ► Artikel lesen | |
| 27.04. | Nanologica AB: Syntagon AB Recruits Alexandra Pichard Nielsen as Vice President Business Development | 1.870 | GlobeNewswire (Europe) | Syntagon AB, a subsidiary of Nanologica AB (publ), has recruited Alexandra Pichard Nielsen to the newly established role of Vice President Business Development. The recruitment is part of the strategy... ► Artikel lesen | |
| 26.03. | Nanologica AB: Nanologica Announces Outcome of Rights Issue | 1.056 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| NANOLOGICA Aktie jetzt für 0€ handeln | |||||
| 06.03. | Nanologica AB: Nanologica Publishes Information Document Regarding Directed Share Issues and Rights Issue | 537 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 05.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.03.2026 | 455 | Xetra Newsboard | Das Instrument 4YD SE0005454873 NANOLOGICA AB EQUITY wird cum Kapitalmassnahme gehandelt am 05.03.2026 und ex Kapitalmassnahme am 06.03.2026 The instrument 4YD SE0005454873 NANOLOGICA AB EQUITY is traded... ► Artikel lesen | |
| 04.03. | Nanologica AB: Bulletin From The Extraordinary General Meeting In Nanologica AB (publ) | 416 | GlobeNewswire (Europe) | Nanologica AB (publ) ("Nanologica" or the "Company") held an extraordinary general meeting today at which the following resolutions were passed.
For more detailed information on the content of the resolutions... ► Artikel lesen | |
| 26.02. | Nanologica AB: Year-End Report 2025 Nanologica AB (publ) | 521 | GlobeNewswire (Europe) | FINANCIAL SUMMARYNet sales for the fourth quarter amounted to SEK 5,205 thousand (6,715) and for the full year to SEK 21,127 thousand (14,538)Operating loss for the quarter amounted to SEK -15,706 thousand... ► Artikel lesen | |
| 02.02. | Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon | 553 | GlobeNewswire (Europe) | Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity... ► Artikel lesen | |
| 30.01. | Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica | 2 | Contract Pharma | ||
| 30.01. | Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million | 1.039 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 29.01. | Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica | 760 | GlobeNewswire (Europe) | Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of... ► Artikel lesen | |
| 23.10.25 | Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ) | 708 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10... ► Artikel lesen | |
| 22.10.25 | Nanologica AB: Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China | 498 | GlobeNewswire (Europe) | Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers.
"This... ► Artikel lesen | |
| 01.10.25 | Nanologica AB: Nanologica AB (publ) Enters the Insulin Market in China | 433 | GlobeNewswire (Europe) | Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media NLAB Saga®. The customer is an insulin manufacturer... ► Artikel lesen | |
| 16.07.25 | The observation status for Nanologica AB (publ) is removed | 1.004 | GlobeNewswire | On May 23, 2025, the shares in Nanologica AB (publ) were given observation status with reference to a public takeover offer from Flerie Invest AB to the shareholders in Nanologica AB (publ).
Today... ► Artikel lesen | |
| 16.07.25 | Flerie AB: Flerie AB's subsidiary Flerie Invest AB announces final outcome of the mandatory cash offer to the shareholders of Nanologica AB (publ) | 798 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE... ► Artikel lesen | |
| 10.07.25 | Nanologica AB: Interim Report Q2 2025 Nanologica AB (publ) | 750 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the second quarter amounted to SEK 2,335 thousand (2,174) and for the first half of the year to SEK 13,087 thousand (7,211)Operating loss for the quarter amounted to... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ONTO INNOVATION | 280,00 | -8,11 % | Oppenheimer raises Onto Innovation stock price target on AI platform strength | ||
| FORMYCON | 19,620 | +0,10 % | Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy | Original-Research: Formycon AG - from First Berlin Equity Research GmbH
22.06.2026 / 08:57 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is... ► Artikel lesen | |
| RIBER | 12,100 | -5,76 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 19.06.2026 | Das Instrument 5DP NO0013711739 DOLPHIN DRILL.A.S. NK 2,5 EQUITY wird ex Kapitalmassnahme gehandelt am 19.06.2026 The instrument 5DP NO0013711739 DOLPHIN DRILL.A.S. NK 2,5 EQUITY is traded ex capital... ► Artikel lesen | |
| NVE | 96,50 | +0,52 % | NVE announces internal CEO transition as Daniel Baker nears retirement | ||
| SOLESENCE | 1,290 | 0,00 % | Solésence, Inc.: Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards | ||
| ZENTEK | 0,356 | +1,14 % | Zentek Ltd: Zentek 18-million-share private placement | ||
| KOPIN | 3,800 | -4,90 % | Kopin Corporation beendet Beteiligung und Lizenzverträge mit Lightning Silicon | ||
| GAUZY | 0,503 | +4,68 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,281 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2026 | Das Instrument G85 CA35958L1013 FUERTE METALS CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2026 und ex Kapitalmassnahme am 10.06.2026 The instrument G85 CA35958L1013 FUERTE METALS CORP.... ► Artikel lesen | |
| OBDUCAT | 0,058 | -8,23 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| GOMSPACE | 1,395 | +0,14 % | GomSpace Group AB: Annual general meeting held in GomSpace Group AB (publ) | Today, the annual general meeting of 2026 has been held in GomSpace Group AB (publ) (the "Company" or "GomSpace"). Below follows a summary of the decisions taken by the annual general meeting (all... ► Artikel lesen | |
| VEECO INSTRUMENTS | 65,00 | -4,10 % | Veeco Instruments Inc.: Veeco Reports First Quarter 2026 Financial Results | First Quarter 2026 Highlights: Revenue of $158.3 million, compared with $167.3 million in the same period last yearGAAP net loss of $(0.3) million, or $(0.01) loss per diluted share, compared with... ► Artikel lesen | |
| ACACIA RESEARCH | 4,040 | 0,00 % | Acacia Research Q1 2026 slides show mixed results, strong liquidity | ||
| ADVANCE ZINCTEK | 0,412 | -0,96 % | ADVANCE ZINCTEK LIMITED: Change in substantial holding | ||
| NANOVIRICIDES | 1,070 | -3,60 % | NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo | SHELTON, CT / ACCESS Newswire / June 22, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today announced that it has shipped the NV-387 Oral Gummies Drug Product for a Phase II Clinical... ► Artikel lesen |